Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Axxelent Pharma Science Private Limited, is an unlisted private company incorporated on 07 October, 2019. It is classified as a private limited company and is located in , Tamil Nadu. It's authorized share capital is INR 175.00 cr and the total paid-up capital is INR 60.86 cr.
Axxelent Pharma Science's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2024. It's book networth has increased by 232.36%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Sampath Kumar Devarajan
Shareholder
|
08565891 | 6 years |
| Director | Subramanian Hariharan
Shareholder
|
05297969 | 4 years |
| Whole-time Director | Chaitanya Devendra
Shareholder
|
06776403 | 4 years |
| Managing Director | Jitesh Devendra
Shareholder
|
06469234 | 5 years |
| Whole-time Director | Sreenivasa Reddy Bhimanatham
Shareholder
|
08955389 | 5 years |
| Nominee Director | Kamlesh Phulwani | 03100409 | 3 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 2
Total Amount : 176.0 cr
IDFC First Bank Limited
No. of Loans: 2
Total Amount : 130.0 cr
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| MAIVA LIFESCIENCES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Tamil Nadu |
| MEDSURGE GLOBAL BUSINESS OPERATIONS LLP |
Active
|
10.0 L | 1 | Karnataka |
| MEDICIANZ PHARMAMEDI PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| SHASUN NBI NANOTECH INDIA PRIVATE LIMITE D |
Strike Off
|
1.0 L | 1 | Tamil Nadu |
| SHASUN LEASING AND FINANCE PVT LTD |
Active
|
72.7 L | 2 | Pondicherry |
| AVANTHIYA PHARMA LLP |
Converted to CMP and Dissolved
|
87.0 L | 2 | Nadu |
| AXXINOVAR PHARMA PRIVATE LIMITED |
Active
|
1.5 L | 2 | Tamil Nadu |
| AVANTHIYA PHARMA PRIVATE LIMITED |
Active
|
87.0 L | 1 | Tamil Nadu |
| AXXELENT PHARMACEUTICALS PRIVATE LIMITED |
Strike Off
|
10.0 L | 1 | Tamil Nadu |
Read more
The incorporation date of AXXELENT PHARMA SCIENCE PRIVATE LIMITED is 07 October, 2019
The authorized share capital of AXXELENT PHARMA SCIENCE PRIVATE LIMITED is INR ₹ 175.0 Cr.
The paid-up capital of AXXELENT PHARMA SCIENCE PRIVATE LIMITED is INR ₹ 60.9 Cr.
The registered address of AXXELENT PHARMA SCIENCE PRIVATE LIMITED is No. 3 Jagadeeswaran Street, T.Nagar Chennai, Thygarayanagar, Chennai, Chennai, Tamil Nadu, India, 600017 - 600017
The CIN number of AXXELENT PHARMA SCIENCE PRIVATE LIMITED is U24110TN2019PTC131943.